NEW YORK (AP) — Antibiotic maker Cubist Pharmaceuticals said Monday that Michael Bonney will retire as CEO at the end of the year, and the company said it will promote President Robert Perez to take his place.
Bonney will retire as CEO on Dec. 31, and Perez will be promoted the next day. The company said Bonney will become non-executive chairman of its board of directors. Current Chairman Kenneth Bate will become Cubist’s lead independent director.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.